Nanoview Biosciences is developing proprietary products that support research, translation and delivery of precision medicine.
Nanoview Biosciences has raised $2.5M in total funding. The most recent round was Debt Financing. The last funding was announced in March 2022.
Nanoview Biosciences's investors include National Science Foundation, Sands Capital Ventures, MassVentures, Northpond Ventures, PBM Capital Group.
Nanoview Biosciences is headquartered in Boston, United States.
Nanoview Biosciences is developing proprietary products that support research, translation and delivery of precision medicine.
Nanoview Biosciences is at the Debt Financing stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Nanoview Biosciences — Funding & Investors." VCBacked, March 1, 2022, https://www.vcbacked.co/company/nanoview-biosciences. Accessed September 29, 2026.
VCBacked. (2022). Nanoview Biosciences — Funding & Investors. Retrieved September 29, 2026, from https://www.vcbacked.co/company/nanoview-biosciences
{{cite web |title=Nanoview Biosciences — Funding & Investors |url=https://www.vcbacked.co/company/nanoview-biosciences |website=VCBacked |access-date=September 29, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated